Color, a population genomics and healthcare technology company that counts Apple, Verily and, most recently, Sioux Falls, S.D.-based Sanford Health among its partners, has closed a $75 million funding ...

Genetic tests for cancer can run thousands of dollars, but Color Genomics plans to change that: it's offering testing for the cancer risk variants BRCA1 and BRCA2 — as well as 17 others — for $249, ...

An affordable new BRCA gene test has hit the market, but who should take it? — -- A new genetic testing kit that hits the market today is the most affordable, and arguably one of the simplest, ...

Consumer Genetic Testing Market - Global Forecast 2025-2032" report has been added to ResearchAndMarkets.com's offering. The direct-to-consumer genetic testing market is undergoing rapid ...

When the Human Genome Project concluded 21 years ago, it opened the door for genetic testing and a promise for lifesaving screenings and personalized medicine. An innovation that serves as a key ...

When a patient has an inherited cancer-associated gene, it is desirable — but not easy — to have other family members tested. In the United States, the difficulty primarily stems from privacy ...

ROCHESTER, N.Y. – October is Breast Cancer Awareness Month, and genetic testing proved to be lifesaving for the women featured in this story. Jodi Lavery discovered she had a BRCA-2 gene mutation, ...

Aventa Genomics has commercialized the Aventa FusionPlus test, which enables any oncologist or pathologist, whether in a highly specialized comprehensive cancer center or a community hospital, to ...

The global direct-to-consumer genetic testing market size was US$ 1,338.6 million in 2021. The global direct-to-consumer genetic testing market size is forecast to reach US$ 5,573.5 million by 2030, ...